nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—Carbachol—glaucoma	0.599	1	CbGbCtD
Epirubicin—Daunorubicin—CYP1B1—glaucoma	0.00153	0.357	CrCbGaD
Epirubicin—Doxorubicin—NOS3—glaucoma	0.00152	0.353	CrCbGaD
Epirubicin—Doxorubicin—CYP1B1—glaucoma	0.00124	0.29	CrCbGaD
Epirubicin—PLA2G4A—Pindolol—Levobunolol—glaucoma	0.000962	0.223	CbGdCrCtD
Epirubicin—PLA2G4A—Pindolol—Carteolol—glaucoma	0.000962	0.223	CbGdCrCtD
Epirubicin—PLA2G4A—Pindolol—Metipranolol—glaucoma	0.000917	0.213	CbGdCrCtD
Epirubicin—PLA2G4A—Pindolol—Betaxolol—glaucoma	0.000642	0.149	CbGdCrCtD
Epirubicin—TOP2A—Alprenolol—Metipranolol—glaucoma	0.000489	0.113	CbGdCrCtD
Epirubicin—TOP2A—Alprenolol—Betaxolol—glaucoma	0.000342	0.0793	CbGdCrCtD
Epirubicin—ABCC1—S1P1 pathway—VEGFA—glaucoma	0.00029	0.00259	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—FGFR1OP—glaucoma	0.000289	0.00258	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000288	0.00257	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000283	0.00252	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000281	0.00251	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.000276	0.00246	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—RAB8A—glaucoma	0.000272	0.00243	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—MMP1—glaucoma	0.000266	0.00238	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—OPTN—glaucoma	0.000264	0.00235	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—BAD—glaucoma	0.000263	0.00235	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000262	0.00234	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—CAV1—glaucoma	0.000261	0.00233	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—glaucoma	0.00026	0.00232	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—BAD—glaucoma	0.00026	0.00232	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000257	0.0023	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000252	0.00225	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GSTM1—glaucoma	0.000244	0.00218	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—TGFB2—glaucoma	0.00024	0.00214	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—OPTN—glaucoma	0.000236	0.00211	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—glaucoma	0.000235	0.0021	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NGF—glaucoma	0.000233	0.00208	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000232	0.00207	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000231	0.00206	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000228	0.00204	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000226	0.00202	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—FAS—glaucoma	0.000225	0.00201	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTT1—glaucoma	0.000224	0.002	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000224	0.002	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CA1—glaucoma	0.000223	0.00199	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CTSA—glaucoma	0.000216	0.00192	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000214	0.00191	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000213	0.0019	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—BCL2L1—glaucoma	0.000213	0.0019	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS2—glaucoma	0.000212	0.0019	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—glaucoma	0.000212	0.00189	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000211	0.00188	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000207	0.00185	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CA2—glaucoma	0.000204	0.00182	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000202	0.00181	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000199	0.00178	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000199	0.00178	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP2—glaucoma	0.000199	0.00177	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000198	0.00177	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—NOS3—glaucoma	0.000197	0.00176	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—BAD—glaucoma	0.000193	0.00172	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RAB8A—glaucoma	0.00019	0.0017	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—glaucoma	0.000188	0.00167	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS3—glaucoma	0.000186	0.00166	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000185	0.00165	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—CYP1B1—glaucoma	0.000179	0.0016	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—CYP1B1—glaucoma	0.000176	0.00157	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000172	0.00154	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000171	0.00152	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00017	0.00152	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—glaucoma	0.00017	0.00151	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000169	0.00151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000168	0.0015	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—OPTN—glaucoma	0.000165	0.00147	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000164	0.00146	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.000163	0.00146	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—GSTM1—glaucoma	0.000163	0.00145	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS3—glaucoma	0.000163	0.00145	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND2—glaucoma	0.00016	0.00143	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CA5A—glaucoma	0.000157	0.0014	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NARFL—glaucoma	0.000157	0.0014	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000157	0.0014	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000156	0.00139	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	0.000155	0.00138	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CA5A—glaucoma	0.000154	0.00138	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NARFL—glaucoma	0.000154	0.00138	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000151	0.00135	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000151	0.00134	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP9—glaucoma	0.000149	0.00133	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000149	0.00133	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000148	0.00132	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—TXN—glaucoma	0.000143	0.00128	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000143	0.00128	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTM1—glaucoma	0.000143	0.00128	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CCND2—glaucoma	0.000143	0.00128	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—GSTM1—glaucoma	0.000141	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000136	0.00121	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000135	0.00121	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000133	0.00119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000131	0.00117	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000131	0.00117	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00013	0.00116	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN2B—glaucoma	0.000128	0.00114	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—FAS—glaucoma	0.000128	0.00114	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000128	0.00114	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CA5A—glaucoma	0.000123	0.0011	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NARFL—glaucoma	0.000123	0.0011	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND2—glaucoma	0.000121	0.00108	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000118	0.00106	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—glaucoma	0.000118	0.00105	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000116	0.00103	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—OPN4—glaucoma	0.000115	0.00102	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000114	0.00102	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000114	0.00101	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LRP12—glaucoma	0.000112	0.000995	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GSTT1—glaucoma	0.000111	0.000992	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000111	0.000991	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.000109	0.000972	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000109	0.000969	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND2—glaucoma	0.000108	0.000967	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000105	0.000936	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTGFR—glaucoma	0.000103	0.000922	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000101	0.0009	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.89e-05	0.000882	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LRP12—glaucoma	9.78e-05	0.000872	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Pilocarpine—glaucoma	9.76e-05	0.000349	CcSEcCtD
Epirubicin—Gastrointestinal pain—Travoprost—glaucoma	9.74e-05	0.000348	CcSEcCtD
Epirubicin—Loss of consciousness—Clonidine—glaucoma	9.73e-05	0.000347	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDKN2B—glaucoma	9.71e-05	0.000867	CbGpPWpGaD
Epirubicin—Feeling abnormal—Brinzolamide—glaucoma	9.7e-05	0.000346	CcSEcCtD
Epirubicin—Mental disorder—Betaxolol—glaucoma	9.7e-05	0.000346	CcSEcCtD
Epirubicin—Constipation—Pilocarpine—glaucoma	9.67e-05	0.000345	CcSEcCtD
Epirubicin—Pain—Pilocarpine—glaucoma	9.67e-05	0.000345	CcSEcCtD
Epirubicin—Cough—Clonidine—glaucoma	9.66e-05	0.000345	CcSEcCtD
Epirubicin—Sweating—Timolol—glaucoma	9.66e-05	0.000345	CcSEcCtD
Epirubicin—Dizziness—Apraclonidine—glaucoma	9.65e-05	0.000345	CcSEcCtD
Epirubicin—Malnutrition—Betaxolol—glaucoma	9.63e-05	0.000344	CcSEcCtD
Epirubicin—Erythema—Betaxolol—glaucoma	9.63e-05	0.000344	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TNF—glaucoma	9.57e-05	0.000854	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—glaucoma	9.52e-05	0.00085	CbGpPWpGaD
Epirubicin—Urticaria—Dorzolamide—glaucoma	9.51e-05	0.00034	CcSEcCtD
Epirubicin—Epistaxis—Timolol—glaucoma	9.5e-05	0.000339	CcSEcCtD
Epirubicin—Body temperature increased—Dorzolamide—glaucoma	9.46e-05	0.000338	CcSEcCtD
Epirubicin—Abdominal pain—Dorzolamide—glaucoma	9.46e-05	0.000338	CcSEcCtD
Epirubicin—Tension—Betaxolol—glaucoma	9.45e-05	0.000338	CcSEcCtD
Epirubicin—Sinusitis—Timolol—glaucoma	9.45e-05	0.000337	CcSEcCtD
Epirubicin—Dysgeusia—Betaxolol—glaucoma	9.43e-05	0.000337	CcSEcCtD
Epirubicin—Chest pain—Clonidine—glaucoma	9.42e-05	0.000337	CcSEcCtD
Epirubicin—Arthralgia—Clonidine—glaucoma	9.42e-05	0.000337	CcSEcCtD
Epirubicin—Abdominal pain—Travoprost—glaucoma	9.42e-05	0.000336	CcSEcCtD
Epirubicin—Agranulocytosis—Timolol—glaucoma	9.4e-05	0.000336	CcSEcCtD
Epirubicin—Anxiety—Clonidine—glaucoma	9.39e-05	0.000335	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	9.37e-05	0.000836	CbGpPWpGaD
Epirubicin—Asthenia—Acetazolamide—glaucoma	9.37e-05	0.000335	CcSEcCtD
Epirubicin—Dizziness—Bimatoprost—glaucoma	9.36e-05	0.000334	CcSEcCtD
Epirubicin—Nervousness—Betaxolol—glaucoma	9.36e-05	0.000334	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	9.36e-05	0.000334	CcSEcCtD
Epirubicin—Urticaria—Brinzolamide—glaucoma	9.35e-05	0.000334	CcSEcCtD
Epirubicin—Feeling abnormal—Pilocarpine—glaucoma	9.32e-05	0.000333	CcSEcCtD
Epirubicin—Discomfort—Clonidine—glaucoma	9.31e-05	0.000332	CcSEcCtD
Epirubicin—Vomiting—Apraclonidine—glaucoma	9.28e-05	0.000332	CcSEcCtD
Epirubicin—Muscle spasms—Betaxolol—glaucoma	9.26e-05	0.000331	CcSEcCtD
Epirubicin—Gastrointestinal pain—Pilocarpine—glaucoma	9.25e-05	0.00033	CcSEcCtD
Epirubicin—Hypersensitivity—Brimonidine—glaucoma	9.23e-05	0.00033	CcSEcCtD
Epirubicin—Dry mouth—Clonidine—glaucoma	9.21e-05	0.000329	CcSEcCtD
Epirubicin—Bradycardia—Timolol—glaucoma	9.2e-05	0.000329	CcSEcCtD
Epirubicin—Dermatitis—Apraclonidine—glaucoma	9.2e-05	0.000328	CcSEcCtD
Epirubicin—Headache—Apraclonidine—glaucoma	9.14e-05	0.000327	CcSEcCtD
Epirubicin—Confusional state—Clonidine—glaucoma	9.11e-05	0.000325	CcSEcCtD
Epirubicin—Vision blurred—Betaxolol—glaucoma	9.08e-05	0.000324	CcSEcCtD
Epirubicin—Rhinitis—Timolol—glaucoma	9.06e-05	0.000324	CcSEcCtD
Epirubicin—Oedema—Clonidine—glaucoma	9.03e-05	0.000323	CcSEcCtD
Epirubicin—Asthenia—Brimonidine—glaucoma	8.99e-05	0.000321	CcSEcCtD
Epirubicin—Infection—Clonidine—glaucoma	8.97e-05	0.00032	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.97e-05	0.0008	CbGpPWpGaD
Epirubicin—Abdominal pain—Pilocarpine—glaucoma	8.94e-05	0.000319	CcSEcCtD
Epirubicin—Body temperature increased—Pilocarpine—glaucoma	8.94e-05	0.000319	CcSEcCtD
Epirubicin—Ill-defined disorder—Betaxolol—glaucoma	8.94e-05	0.000319	CcSEcCtD
Epirubicin—Diarrhoea—Acetazolamide—glaucoma	8.93e-05	0.000319	CcSEcCtD
Epirubicin—Rash—Bimatoprost—glaucoma	8.92e-05	0.000319	CcSEcCtD
Epirubicin—Dermatitis—Bimatoprost—glaucoma	8.92e-05	0.000318	CcSEcCtD
Epirubicin—Oedema peripheral—Timolol—glaucoma	8.91e-05	0.000318	CcSEcCtD
Epirubicin—Anaemia—Betaxolol—glaucoma	8.9e-05	0.000318	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—FN1—glaucoma	8.9e-05	0.000794	CbGpPWpGaD
Epirubicin—Shock—Clonidine—glaucoma	8.89e-05	0.000317	CcSEcCtD
Epirubicin—Connective tissue disorder—Timolol—glaucoma	8.88e-05	0.000317	CcSEcCtD
Epirubicin—Pruritus—Brimonidine—glaucoma	8.87e-05	0.000317	CcSEcCtD
Epirubicin—Headache—Bimatoprost—glaucoma	8.87e-05	0.000317	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ABCA1—glaucoma	8.86e-05	0.000791	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP1B1—glaucoma	8.86e-05	0.000791	CbGpPWpGaD
Epirubicin—Nervous system disorder—Clonidine—glaucoma	8.86e-05	0.000316	CcSEcCtD
Epirubicin—Thrombocytopenia—Clonidine—glaucoma	8.84e-05	0.000316	CcSEcCtD
Epirubicin—Hypersensitivity—Dorzolamide—glaucoma	8.82e-05	0.000315	CcSEcCtD
Epirubicin—Tachycardia—Clonidine—glaucoma	8.81e-05	0.000315	CcSEcCtD
Epirubicin—Hypersensitivity—Travoprost—glaucoma	8.78e-05	0.000314	CcSEcCtD
Epirubicin—Skin disorder—Clonidine—glaucoma	8.77e-05	0.000313	CcSEcCtD
Epirubicin—Hyperhidrosis—Clonidine—glaucoma	8.73e-05	0.000312	CcSEcCtD
Epirubicin—Visual impairment—Timolol—glaucoma	8.71e-05	0.000311	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—TGFB2—glaucoma	8.7e-05	0.000776	CbGpPWpGaD
Epirubicin—Malaise—Betaxolol—glaucoma	8.69e-05	0.00031	CcSEcCtD
Epirubicin—Nausea—Apraclonidine—glaucoma	8.67e-05	0.00031	CcSEcCtD
Epirubicin—Hypersensitivity—Brinzolamide—glaucoma	8.67e-05	0.00031	CcSEcCtD
Epirubicin—Vertigo—Betaxolol—glaucoma	8.66e-05	0.000309	CcSEcCtD
Epirubicin—Syncope—Betaxolol—glaucoma	8.64e-05	0.000309	CcSEcCtD
Epirubicin—Dizziness—Acetazolamide—glaucoma	8.63e-05	0.000308	CcSEcCtD
Epirubicin—Anorexia—Clonidine—glaucoma	8.61e-05	0.000307	CcSEcCtD
Epirubicin—Asthenia—Dorzolamide—glaucoma	8.59e-05	0.000307	CcSEcCtD
Epirubicin—Asthenia—Travoprost—glaucoma	8.55e-05	0.000305	CcSEcCtD
Epirubicin—Palpitations—Betaxolol—glaucoma	8.51e-05	0.000304	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	8.48e-05	0.000756	CbGpPWpGaD
Epirubicin—Pruritus—Dorzolamide—glaucoma	8.47e-05	0.000302	CcSEcCtD
Epirubicin—Loss of consciousness—Betaxolol—glaucoma	8.47e-05	0.000302	CcSEcCtD
Epirubicin—Eye disorder—Timolol—glaucoma	8.45e-05	0.000302	CcSEcCtD
Epirubicin—Asthenia—Brinzolamide—glaucoma	8.44e-05	0.000302	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TP53—glaucoma	8.44e-05	0.000753	CbGpPWpGaD
Epirubicin—Hypotension—Clonidine—glaucoma	8.44e-05	0.000301	CcSEcCtD
Epirubicin—Pruritus—Travoprost—glaucoma	8.43e-05	0.000301	CcSEcCtD
Epirubicin—Tinnitus—Timolol—glaucoma	8.43e-05	0.000301	CcSEcCtD
Epirubicin—Cough—Betaxolol—glaucoma	8.41e-05	0.0003	CcSEcCtD
Epirubicin—Nausea—Bimatoprost—glaucoma	8.41e-05	0.0003	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.39e-05	0.000749	CbGpPWpGaD
Epirubicin—Cardiac disorder—Timolol—glaucoma	8.39e-05	0.0003	CcSEcCtD
Epirubicin—Hypersensitivity—Pilocarpine—glaucoma	8.33e-05	0.000298	CcSEcCtD
Epirubicin—Pruritus—Brinzolamide—glaucoma	8.32e-05	0.000297	CcSEcCtD
Epirubicin—Vomiting—Acetazolamide—glaucoma	8.3e-05	0.000297	CcSEcCtD
Epirubicin—Dizziness—Brimonidine—glaucoma	8.29e-05	0.000296	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Clonidine—glaucoma	8.23e-05	0.000294	CcSEcCtD
Epirubicin—Angiopathy—Timolol—glaucoma	8.2e-05	0.000293	CcSEcCtD
Epirubicin—Myalgia—Betaxolol—glaucoma	8.2e-05	0.000293	CcSEcCtD
Epirubicin—Chest pain—Betaxolol—glaucoma	8.2e-05	0.000293	CcSEcCtD
Epirubicin—Arthralgia—Betaxolol—glaucoma	8.2e-05	0.000293	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2A—glaucoma	8.2e-05	0.000731	CbGpPWpGaD
Epirubicin—Diarrhoea—Dorzolamide—glaucoma	8.19e-05	0.000293	CcSEcCtD
Epirubicin—Headache—Acetazolamide—glaucoma	8.18e-05	0.000292	CcSEcCtD
Epirubicin—Anxiety—Betaxolol—glaucoma	8.17e-05	0.000292	CcSEcCtD
Epirubicin—Insomnia—Clonidine—glaucoma	8.17e-05	0.000292	CcSEcCtD
Epirubicin—Immune system disorder—Timolol—glaucoma	8.17e-05	0.000292	CcSEcCtD
Epirubicin—Diarrhoea—Travoprost—glaucoma	8.15e-05	0.000291	CcSEcCtD
Epirubicin—Mediastinal disorder—Timolol—glaucoma	8.15e-05	0.000291	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	8.15e-05	0.000291	CcSEcCtD
Epirubicin—Asthenia—Pilocarpine—glaucoma	8.11e-05	0.00029	CcSEcCtD
Epirubicin—Paraesthesia—Clonidine—glaucoma	8.11e-05	0.00029	CcSEcCtD
Epirubicin—Discomfort—Betaxolol—glaucoma	8.1e-05	0.000289	CcSEcCtD
Epirubicin—Arrhythmia—Timolol—glaucoma	8.08e-05	0.000288	CcSEcCtD
Epirubicin—Dyspnoea—Clonidine—glaucoma	8.05e-05	0.000288	CcSEcCtD
Epirubicin—Diarrhoea—Brinzolamide—glaucoma	8.05e-05	0.000288	CcSEcCtD
Epirubicin—Somnolence—Clonidine—glaucoma	8.03e-05	0.000287	CcSEcCtD
Epirubicin—Dry mouth—Betaxolol—glaucoma	8.02e-05	0.000287	CcSEcCtD
Epirubicin—Pruritus—Pilocarpine—glaucoma	8e-05	0.000286	CcSEcCtD
Epirubicin—Alopecia—Timolol—glaucoma	7.99e-05	0.000285	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.95e-05	0.000709	CbGpPWpGaD
Epirubicin—Confusional state—Betaxolol—glaucoma	7.93e-05	0.000283	CcSEcCtD
Epirubicin—Mental disorder—Timolol—glaucoma	7.92e-05	0.000283	CcSEcCtD
Epirubicin—Dizziness—Dorzolamide—glaucoma	7.91e-05	0.000283	CcSEcCtD
Epirubicin—Rash—Brimonidine—glaucoma	7.9e-05	0.000282	CcSEcCtD
Epirubicin—Dermatitis—Brimonidine—glaucoma	7.89e-05	0.000282	CcSEcCtD
Epirubicin—Dizziness—Travoprost—glaucoma	7.88e-05	0.000281	CcSEcCtD
Epirubicin—Malnutrition—Timolol—glaucoma	7.87e-05	0.000281	CcSEcCtD
Epirubicin—Erythema—Timolol—glaucoma	7.87e-05	0.000281	CcSEcCtD
Epirubicin—Oedema—Betaxolol—glaucoma	7.86e-05	0.000281	CcSEcCtD
Epirubicin—Headache—Brimonidine—glaucoma	7.85e-05	0.00028	CcSEcCtD
Epirubicin—Decreased appetite—Clonidine—glaucoma	7.85e-05	0.00028	CcSEcCtD
Epirubicin—Infection—Betaxolol—glaucoma	7.81e-05	0.000279	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Clonidine—glaucoma	7.8e-05	0.000279	CcSEcCtD
Epirubicin—Fatigue—Clonidine—glaucoma	7.79e-05	0.000278	CcSEcCtD
Epirubicin—Dizziness—Brinzolamide—glaucoma	7.78e-05	0.000278	CcSEcCtD
Epirubicin—Nausea—Acetazolamide—glaucoma	7.76e-05	0.000277	CcSEcCtD
Epirubicin—Diarrhoea—Pilocarpine—glaucoma	7.74e-05	0.000276	CcSEcCtD
Epirubicin—Shock—Betaxolol—glaucoma	7.74e-05	0.000276	CcSEcCtD
Epirubicin—Tension—Timolol—glaucoma	7.72e-05	0.000276	CcSEcCtD
Epirubicin—Constipation—Clonidine—glaucoma	7.72e-05	0.000276	CcSEcCtD
Epirubicin—Pain—Clonidine—glaucoma	7.72e-05	0.000276	CcSEcCtD
Epirubicin—Nervous system disorder—Betaxolol—glaucoma	7.71e-05	0.000275	CcSEcCtD
Epirubicin—Dysgeusia—Timolol—glaucoma	7.71e-05	0.000275	CcSEcCtD
Epirubicin—Thrombocytopenia—Betaxolol—glaucoma	7.7e-05	0.000275	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CA1—glaucoma	7.68e-05	0.000685	CbGpPWpGaD
Epirubicin—Tachycardia—Betaxolol—glaucoma	7.67e-05	0.000274	CcSEcCtD
Epirubicin—Nervousness—Timolol—glaucoma	7.64e-05	0.000273	CcSEcCtD
Epirubicin—Skin disorder—Betaxolol—glaucoma	7.64e-05	0.000273	CcSEcCtD
Epirubicin—Vomiting—Dorzolamide—glaucoma	7.61e-05	0.000272	CcSEcCtD
Epirubicin—Hyperhidrosis—Betaxolol—glaucoma	7.6e-05	0.000272	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	7.6e-05	0.000678	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND2—glaucoma	7.58e-05	0.000676	CbGpPWpGaD
Epirubicin—Rash—Dorzolamide—glaucoma	7.55e-05	0.00027	CcSEcCtD
Epirubicin—Dermatitis—Dorzolamide—glaucoma	7.54e-05	0.000269	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CA1—glaucoma	7.53e-05	0.000672	CbGpPWpGaD
Epirubicin—Rash—Travoprost—glaucoma	7.51e-05	0.000268	CcSEcCtD
Epirubicin—Dermatitis—Travoprost—glaucoma	7.51e-05	0.000268	CcSEcCtD
Epirubicin—Headache—Dorzolamide—glaucoma	7.5e-05	0.000268	CcSEcCtD
Epirubicin—Anorexia—Betaxolol—glaucoma	7.49e-05	0.000268	CcSEcCtD
Epirubicin—Vomiting—Brinzolamide—glaucoma	7.48e-05	0.000267	CcSEcCtD
Epirubicin—Dizziness—Pilocarpine—glaucoma	7.48e-05	0.000267	CcSEcCtD
Epirubicin—Headache—Travoprost—glaucoma	7.47e-05	0.000267	CcSEcCtD
Epirubicin—Nausea—Brimonidine—glaucoma	7.44e-05	0.000266	CcSEcCtD
Epirubicin—Feeling abnormal—Clonidine—glaucoma	7.44e-05	0.000266	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CTSA—glaucoma	7.44e-05	0.000664	CbGpPWpGaD
Epirubicin—Rash—Brinzolamide—glaucoma	7.42e-05	0.000265	CcSEcCtD
Epirubicin—Vision blurred—Timolol—glaucoma	7.42e-05	0.000265	CcSEcCtD
Epirubicin—Dermatitis—Brinzolamide—glaucoma	7.41e-05	0.000265	CcSEcCtD
Epirubicin—Gastrointestinal pain—Clonidine—glaucoma	7.39e-05	0.000264	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.38e-05	0.000659	CbGpPWpGaD
Epirubicin—Headache—Brinzolamide—glaucoma	7.37e-05	0.000263	CcSEcCtD
Epirubicin—Hypotension—Betaxolol—glaucoma	7.35e-05	0.000262	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CDKN2A—glaucoma	7.33e-05	0.000654	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CTSA—glaucoma	7.3e-05	0.000651	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.27e-05	0.000649	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1B—glaucoma	7.26e-05	0.000648	CbGpPWpGaD
Epirubicin—Vomiting—Pilocarpine—glaucoma	7.19e-05	0.000257	CcSEcCtD
Epirubicin—ABCC1—Disease—FGFR1OP—glaucoma	7.19e-05	0.000641	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HEYL—glaucoma	7.19e-05	0.000641	CbGpPWpGaD
Epirubicin—Urticaria—Clonidine—glaucoma	7.17e-05	0.000256	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Betaxolol—glaucoma	7.16e-05	0.000256	CcSEcCtD
Epirubicin—Body temperature increased—Clonidine—glaucoma	7.14e-05	0.000255	CcSEcCtD
Epirubicin—Abdominal pain—Clonidine—glaucoma	7.14e-05	0.000255	CcSEcCtD
Epirubicin—Rash—Pilocarpine—glaucoma	7.13e-05	0.000255	CcSEcCtD
Epirubicin—Dermatitis—Pilocarpine—glaucoma	7.12e-05	0.000254	CcSEcCtD
Epirubicin—Insomnia—Betaxolol—glaucoma	7.11e-05	0.000254	CcSEcCtD
Epirubicin—Nausea—Dorzolamide—glaucoma	7.11e-05	0.000254	CcSEcCtD
Epirubicin—Headache—Pilocarpine—glaucoma	7.08e-05	0.000253	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GSTM1—glaucoma	7.08e-05	0.000632	CbGpPWpGaD
Epirubicin—Nausea—Travoprost—glaucoma	7.08e-05	0.000253	CcSEcCtD
Epirubicin—Vertigo—Timolol—glaucoma	7.07e-05	0.000253	CcSEcCtD
Epirubicin—Paraesthesia—Betaxolol—glaucoma	7.06e-05	0.000252	CcSEcCtD
Epirubicin—Syncope—Timolol—glaucoma	7.06e-05	0.000252	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CA2—glaucoma	7.03e-05	0.000627	CbGpPWpGaD
Epirubicin—Dyspnoea—Betaxolol—glaucoma	7.01e-05	0.00025	CcSEcCtD
Epirubicin—Nausea—Brinzolamide—glaucoma	6.99e-05	0.00025	CcSEcCtD
Epirubicin—Palpitations—Timolol—glaucoma	6.96e-05	0.000248	CcSEcCtD
Epirubicin—Dyspepsia—Betaxolol—glaucoma	6.92e-05	0.000247	CcSEcCtD
Epirubicin—Loss of consciousness—Timolol—glaucoma	6.92e-05	0.000247	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CA2—glaucoma	6.89e-05	0.000615	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.89e-05	0.000614	CbGpPWpGaD
Epirubicin—Cough—Timolol—glaucoma	6.87e-05	0.000245	CcSEcCtD
Epirubicin—Decreased appetite—Betaxolol—glaucoma	6.84e-05	0.000244	CcSEcCtD
Epirubicin—Hypertension—Timolol—glaucoma	6.8e-05	0.000243	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CDKN2B—glaucoma	6.79e-05	0.000606	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Betaxolol—glaucoma	6.79e-05	0.000242	CcSEcCtD
Epirubicin—Fatigue—Betaxolol—glaucoma	6.78e-05	0.000242	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—OPN4—glaucoma	6.78e-05	0.000605	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.74e-05	0.000601	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.74e-05	0.000601	CbGpPWpGaD
Epirubicin—Pain—Betaxolol—glaucoma	6.72e-05	0.00024	CcSEcCtD
Epirubicin—Constipation—Betaxolol—glaucoma	6.72e-05	0.00024	CcSEcCtD
Epirubicin—Nausea—Pilocarpine—glaucoma	6.72e-05	0.00024	CcSEcCtD
Epirubicin—Chest pain—Timolol—glaucoma	6.7e-05	0.000239	CcSEcCtD
Epirubicin—Myalgia—Timolol—glaucoma	6.7e-05	0.000239	CcSEcCtD
Epirubicin—Arthralgia—Timolol—glaucoma	6.7e-05	0.000239	CcSEcCtD
Epirubicin—Anxiety—Timolol—glaucoma	6.68e-05	0.000239	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	6.65e-05	0.000238	CcSEcCtD
Epirubicin—Hypersensitivity—Clonidine—glaucoma	6.65e-05	0.000238	CcSEcCtD
Epirubicin—Discomfort—Timolol—glaucoma	6.62e-05	0.000236	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.61e-05	0.00059	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SOD1—glaucoma	6.59e-05	0.000588	CbGpPWpGaD
Epirubicin—Dry mouth—Timolol—glaucoma	6.55e-05	0.000234	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CDKN1B—glaucoma	6.49e-05	0.000579	CbGpPWpGaD
Epirubicin—Asthenia—Clonidine—glaucoma	6.48e-05	0.000231	CcSEcCtD
Epirubicin—Feeling abnormal—Betaxolol—glaucoma	6.48e-05	0.000231	CcSEcCtD
Epirubicin—Confusional state—Timolol—glaucoma	6.48e-05	0.000231	CcSEcCtD
Epirubicin—Anaphylactic shock—Timolol—glaucoma	6.42e-05	0.000229	CcSEcCtD
Epirubicin—Oedema—Timolol—glaucoma	6.42e-05	0.000229	CcSEcCtD
Epirubicin—Pruritus—Clonidine—glaucoma	6.39e-05	0.000228	CcSEcCtD
Epirubicin—Infection—Timolol—glaucoma	6.38e-05	0.000228	CcSEcCtD
Epirubicin—Shock—Timolol—glaucoma	6.32e-05	0.000226	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—HEYL—glaucoma	6.3e-05	0.000562	CbGpPWpGaD
Epirubicin—Nervous system disorder—Timolol—glaucoma	6.3e-05	0.000225	CcSEcCtD
Epirubicin—DHCR7—Metabolism—MTHFR—glaucoma	6.26e-05	0.000559	CbGpPWpGaD
Epirubicin—Urticaria—Betaxolol—glaucoma	6.25e-05	0.000223	CcSEcCtD
Epirubicin—Skin disorder—Timolol—glaucoma	6.24e-05	0.000223	CcSEcCtD
Epirubicin—Body temperature increased—Betaxolol—glaucoma	6.22e-05	0.000222	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—glaucoma	6.21e-05	0.000554	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Timolol—glaucoma	6.21e-05	0.000222	CcSEcCtD
Epirubicin—Diarrhoea—Clonidine—glaucoma	6.18e-05	0.000221	CcSEcCtD
Epirubicin—Anorexia—Timolol—glaucoma	6.12e-05	0.000219	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PTGFR—glaucoma	6.1e-05	0.000544	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CA1—glaucoma	6.02e-05	0.000537	CbGpPWpGaD
Epirubicin—Hypotension—Timolol—glaucoma	6e-05	0.000214	CcSEcCtD
Epirubicin—Dizziness—Clonidine—glaucoma	5.97e-05	0.000213	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Timolol—glaucoma	5.85e-05	0.000209	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CTSA—glaucoma	5.83e-05	0.00052	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—APOE—glaucoma	5.83e-05	0.00052	CbGpPWpGaD
Epirubicin—Insomnia—Timolol—glaucoma	5.81e-05	0.000208	CcSEcCtD
Epirubicin—Hypersensitivity—Betaxolol—glaucoma	5.79e-05	0.000207	CcSEcCtD
Epirubicin—DHCR7—Metabolism—CAV1—glaucoma	5.78e-05	0.000515	CbGpPWpGaD
Epirubicin—Paraesthesia—Timolol—glaucoma	5.77e-05	0.000206	CcSEcCtD
Epirubicin—Vomiting—Clonidine—glaucoma	5.74e-05	0.000205	CcSEcCtD
Epirubicin—Dyspnoea—Timolol—glaucoma	5.73e-05	0.000205	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.73e-05	0.000511	CbGpPWpGaD
Epirubicin—Somnolence—Timolol—glaucoma	5.71e-05	0.000204	CcSEcCtD
Epirubicin—Rash—Clonidine—glaucoma	5.69e-05	0.000203	CcSEcCtD
Epirubicin—Dermatitis—Clonidine—glaucoma	5.69e-05	0.000203	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.67e-05	0.000505	CbGpPWpGaD
Epirubicin—Headache—Clonidine—glaucoma	5.66e-05	0.000202	CcSEcCtD
Epirubicin—Dyspepsia—Timolol—glaucoma	5.65e-05	0.000202	CcSEcCtD
Epirubicin—Asthenia—Betaxolol—glaucoma	5.64e-05	0.000202	CcSEcCtD
Epirubicin—Decreased appetite—Timolol—glaucoma	5.58e-05	0.000199	CcSEcCtD
Epirubicin—Pruritus—Betaxolol—glaucoma	5.56e-05	0.000199	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—glaucoma	5.55e-05	0.000496	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Timolol—glaucoma	5.55e-05	0.000198	CcSEcCtD
Epirubicin—Fatigue—Timolol—glaucoma	5.54e-05	0.000198	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CA2—glaucoma	5.51e-05	0.000491	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1B—glaucoma	5.5e-05	0.000491	CbGpPWpGaD
Epirubicin—Pain—Timolol—glaucoma	5.49e-05	0.000196	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.38e-05	0.00048	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.38e-05	0.00048	CbGpPWpGaD
Epirubicin—Diarrhoea—Betaxolol—glaucoma	5.38e-05	0.000192	CcSEcCtD
Epirubicin—Nausea—Clonidine—glaucoma	5.36e-05	0.000192	CcSEcCtD
Epirubicin—Feeling abnormal—Timolol—glaucoma	5.29e-05	0.000189	CcSEcCtD
Epirubicin—Gastrointestinal pain—Timolol—glaucoma	5.25e-05	0.000188	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—SMO—glaucoma	5.21e-05	0.000465	CbGpPWpGaD
Epirubicin—Dizziness—Betaxolol—glaucoma	5.2e-05	0.000186	CcSEcCtD
Epirubicin—Urticaria—Timolol—glaucoma	5.1e-05	0.000182	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	5.1e-05	0.000455	CbGpPWpGaD
Epirubicin—Body temperature increased—Timolol—glaucoma	5.08e-05	0.000181	CcSEcCtD
Epirubicin—Abdominal pain—Timolol—glaucoma	5.08e-05	0.000181	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MMP1—glaucoma	5.03e-05	0.000449	CbGpPWpGaD
Epirubicin—Vomiting—Betaxolol—glaucoma	5e-05	0.000179	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.99e-05	0.000446	CbGpPWpGaD
Epirubicin—Rash—Betaxolol—glaucoma	4.96e-05	0.000177	CcSEcCtD
Epirubicin—Dermatitis—Betaxolol—glaucoma	4.95e-05	0.000177	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—TXN—glaucoma	4.95e-05	0.000442	CbGpPWpGaD
Epirubicin—Headache—Betaxolol—glaucoma	4.93e-05	0.000176	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—glaucoma	4.92e-05	0.000439	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.91e-05	0.000438	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TXN—glaucoma	4.86e-05	0.000433	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CAV1—glaucoma	4.82e-05	0.00043	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—glaucoma	4.8e-05	0.000428	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RPTOR—glaucoma	4.77e-05	0.000426	CbGpPWpGaD
Epirubicin—Hypersensitivity—Timolol—glaucoma	4.73e-05	0.000169	CcSEcCtD
Epirubicin—Nausea—Betaxolol—glaucoma	4.67e-05	0.000167	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NCK2—glaucoma	4.62e-05	0.000413	CbGpPWpGaD
Epirubicin—Asthenia—Timolol—glaucoma	4.61e-05	0.000165	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—FN1—glaucoma	4.59e-05	0.000409	CbGpPWpGaD
Epirubicin—Pruritus—Timolol—glaucoma	4.54e-05	0.000162	CcSEcCtD
Epirubicin—ABCC1—Disease—HDAC9—glaucoma	4.49e-05	0.0004	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.43e-05	0.000395	CbGpPWpGaD
Epirubicin—Diarrhoea—Timolol—glaucoma	4.39e-05	0.000157	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.39e-05	0.000392	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—glaucoma	4.37e-05	0.00039	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	4.34e-05	0.000388	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.33e-05	0.000386	CbGpPWpGaD
Epirubicin—Dizziness—Timolol—glaucoma	4.25e-05	0.000152	CcSEcCtD
Epirubicin—Vomiting—Timolol—glaucoma	4.08e-05	0.000146	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—TP53—glaucoma	4.08e-05	0.000364	CbGpPWpGaD
Epirubicin—Rash—Timolol—glaucoma	4.05e-05	0.000145	CcSEcCtD
Epirubicin—Dermatitis—Timolol—glaucoma	4.05e-05	0.000145	CcSEcCtD
Epirubicin—Headache—Timolol—glaucoma	4.02e-05	0.000144	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—glaucoma	3.99e-05	0.000356	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HDAC9—glaucoma	3.93e-05	0.000351	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—glaucoma	3.88e-05	0.000347	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TXN—glaucoma	3.88e-05	0.000346	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	3.85e-05	0.000343	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—glaucoma	3.84e-05	0.000343	CbGpPWpGaD
Epirubicin—Nausea—Timolol—glaucoma	3.82e-05	0.000136	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GSTT1—glaucoma	3.76e-05	0.000336	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—glaucoma	3.65e-05	0.000325	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.54e-05	0.000316	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.51e-05	0.000313	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—glaucoma	3.44e-05	0.000307	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—glaucoma	3.43e-05	0.000306	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—glaucoma	3.09e-05	0.000276	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SMO—glaucoma	3.08e-05	0.000275	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCA1—glaucoma	3.06e-05	0.000273	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1B1—glaucoma	3.06e-05	0.000273	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.04e-05	0.000271	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—glaucoma	3.01e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—glaucoma	3e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1B1—glaucoma	3e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCA1—glaucoma	3e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK2—glaucoma	2.81e-05	0.000251	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—glaucoma	2.63e-05	0.000234	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—glaucoma	2.45e-05	0.000218	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.43e-05	0.000216	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NGFR—glaucoma	2.41e-05	0.000215	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN2B—glaucoma	2.41e-05	0.000215	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—glaucoma	2.4e-05	0.000214	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCA1—glaucoma	2.4e-05	0.000214	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1B1—glaucoma	2.4e-05	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK1—glaucoma	2.29e-05	0.000205	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—glaucoma	2.16e-05	0.000193	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—glaucoma	2.16e-05	0.000193	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—glaucoma	2.12e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN2B—glaucoma	2.11e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—glaucoma	2.03e-05	0.000181	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—glaucoma	2.02e-05	0.00018	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOE—glaucoma	2.01e-05	0.00018	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAV1—glaucoma	1.99e-05	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—glaucoma	1.98e-05	0.000177	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOE—glaucoma	1.97e-05	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAV1—glaucoma	1.95e-05	0.000174	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—glaucoma	1.92e-05	0.000171	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOE—glaucoma	1.88e-05	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CAV1—glaucoma	1.87e-05	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NGF—glaucoma	1.86e-05	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—glaucoma	1.77e-05	0.000158	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BAD—glaucoma	1.75e-05	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—glaucoma	1.69e-05	0.000151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOE—glaucoma	1.65e-05	0.000147	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CAV1—glaucoma	1.63e-05	0.000146	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOE—glaucoma	1.58e-05	0.000141	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAV1—glaucoma	1.56e-05	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—glaucoma	1.56e-05	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BAD—glaucoma	1.54e-05	0.000137	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—glaucoma	1.51e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—glaucoma	1.48e-05	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—glaucoma	1.41e-05	0.000126	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—glaucoma	1.38e-05	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—glaucoma	1.35e-05	0.000121	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—glaucoma	1.29e-05	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—glaucoma	1.24e-05	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—glaucoma	1.22e-05	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—glaucoma	1.18e-05	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—glaucoma	1.08e-05	9.64e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—glaucoma	1.07e-05	9.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—glaucoma	9.92e-06	8.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—glaucoma	8.9e-06	7.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—glaucoma	6.73e-06	6e-05	CbGpPWpGaD
